Contrarian Codex — Buying more LIB in the $0.60s
"I don't see any clear reason for this current sell-off beyond investors being afraid of further dilution … both of which were already expected" — a second averaging-down add, justified by diagnosing the selling rather than by re-arguing the valuation.
One-line take: A single-paragraph buy note averaging down in LibertyStream (
LIB) again — into the $0.60s, roughly a quarter below the C$0.80 add of
2026-JUL-13. The argument this time is diagnostic rather than valuation-based: he can find "no clear reason for this current sell-off" other than dilution fear, and dismisses that fear as already-priced — the two plausible reasons to issue stock ("capex spending or the expected US uplisting") "were already expected." The forward case rests on the first facility reaching production
this year plus "various catalysts in the pipeline over the coming quarters," and the risk sentence is carried over unaltered: "it's a pre-revenue company that is yet to bring their first facility online, so not without risk."
1. Stocks & names mentioned
| Ticker | Name | Research | View | What he said | At |
| LIB | LibertyStream | — | Positive | "Buying more LIB as it dipped into the $0.60s as I don't see any clear reason for this current sell-off beyond investors being afraid of further dilution (either for capex spending or the expected US uplisting, both of which were already expected)." The bull case: "a lot of potential … as they look to bring their first facility into production this year," with "various catalysts in the pipeline over the coming quarters." The risk is kept explicit — "a pre-revenue company that is yet to bring their first facility online, so not without risk." | read ↗ |
2. Talking points
The add is justified by diagnosing the selling, not by re-arguing the valuation
- "I don't see any clear reason for this current sell-off beyond investors being afraid of further dilution." The July add was framed on cheapness ("dirt cheap" on a five-year conditional); this one is framed on the absence of a fundamental cause — he looks for what changed at the company, finds nothing, and treats the drawdown as sentiment.
- The dilution fear is dismissed on the grounds that it is not new information: the two candidate reasons to issue stock — "capex spending or the expected US uplisting" — were "both … already expected." A known risk re-pricing a stock is a price move without an information move.
A US uplisting is treated as a scheduled event, not a surprise
- The "expected US uplisting" is named in passing as already inside his base case — worth noting because an uplisting is usually accompanied by a raise, so the market's fear and his expectation are the same fact read with opposite signs.
- He gives no date or venue for the uplisting; it is a stated expectation, not a catalyst he is timing.
First facility into production "this year" is the load-bearing milestone
- "There is a lot of potential when it comes to this company as they look to bring their first facility into production this year" — the thesis compresses to a single dated operational event, with "various catalysts in the pipeline over the coming quarters" behind it.
- No catalyst is enumerated, so that part is directional; the checkable item is the facility start-up itself, which either happens inside the year or does not.
The risk sentence is unchanged from July — and it is the same risk
- "But again it's a pre-revenue company that is yet to bring their first facility online, so not without risk." The word "again" does the work: a repeat of the July caveat, not an upgrade in safety after a ~25% lower price.
- Note what the two notes share — the entry price falls, the risk description does not. He is buying more of the same risk cheaper, which is the honest version of averaging down rather than quietly softening the caveats as the position grows.
3. In plain English
LIB — LibertyStream Positive
LibertyStream is trying to pull lithium out of the salty water that comes up as waste alongside oil in the Permian Basin, using "direct lithium extraction" — a chemical filtering step instead of the traditional method of evaporating brine in ponds for many months. The feedstock is water oil producers already pay to dispose of, which is why the targeted cost of production sits far below much of the industry. But nothing is producing yet: the company has no revenue, and its first plant is only now being built.
The shares have fallen into the $0.60s, roughly a quarter below the C$0.80 Mart paid when he added in July, and his reason for buying more is that he cannot find anything wrong at the company to explain the drop. His read is that investors are selling because they fear the company will issue new shares — which shrinks each existing owner's slice of the business — either to pay for building the plant or alongside the planned move to list the shares on a US exchange. His counter is that both of those were already expected, so the market is re-pricing a risk everyone already knew about rather than reacting to news.
What would actually change the picture is the first facility starting production, which the company is aiming to do this year, with further milestones over the following quarters. He does not soften the warning to match the bigger position: this is still a company with no revenue that has never operated a plant, so a delay, a cost overrun or a badly-priced share issue could all hurt from here. He is buying the same risk at a lower price, not a safer one.
Analysis distilled from a Contrarian Codex Discord message (linked above). For personal study — not investment advice. Source material © Contrarian Codex / "Mart".